Harrow (HROW) Cash & Equivalents (2010 - 2026)

Harrow's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $94.6 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 41.84% year-over-year to $94.6 million in Q1 2026; TTM through Mar 2026 was $94.6 million, a 41.84% increase from a year earlier, with the FY2025 full-year figure at $72.9 million, up 54.35% from the prior year.
• Cash & Equivalents grew to $94.6 million in Q1 2026 per HROW's latest filing, from $72.9 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $96.3 million in Q4 2022 and bottomed at $19.2 million in Q1 2023.
• The 5-year median for Cash & Equivalents is $66.7 million (2025), against an average of $60.7 million.
• Across the five-year window, Cash & Equivalents surged 544.96% in 2022 and tumbled 54.11% in 2023, its largest moves.
• Year by year, Cash & Equivalents stood at $96.3 million in 2022, then retreated by 23.04% to $74.1 million in 2023, then sank by 36.23% to $47.2 million in 2024, then surged by 54.35% to $72.9 million in 2025, then gained by 29.78% to $94.6 million in 2026.
• Per Business Quant, the three latest HROW Cash & Equivalents figures stand at $94.6 million (Q1 2026), $72.9 million (Q4 2025), and $74.3 million (Q3 2025).